Cargando…
Treating Neurogenic Lower Urinary Tract Dysfunction in Chronic Spinal Cord Injury Patients—When Intravesical Botox Injection or Urethral Botox Injection Are Indicated
Lower urinary tract symptoms (LUTS), such as urgency, urinary incontinence, and/or difficulty voiding, hamper the quality of life (QoL) of patients with spinal cord injury (SCI). If not managed adequately, urological complications, such as urinary tract infection or renal function deterioration, may...
Autores principales: | Chen, Po-Cheng, Lee, Kau-Han, Lee, Wei-Chia, Yeh, Ting-Chun, Kuo, Yuh-Chen, Chiang, Bing-Juin, Liao, Chun-Hou, Meng, En, Kao, Yao-Lin, Lee, Yung-Chin, Kuo, Hann-Chorng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10145925/ https://www.ncbi.nlm.nih.gov/pubmed/37104226 http://dx.doi.org/10.3390/toxins15040288 |
Ejemplares similares
-
Adverse Events of Intravesical OnabotulinumtoxinA Injection between Patients with Overactive Bladder and Interstitial Cystitis—Different Mechanisms of Action of Botox on Bladder Dysfunction?
por: Kuo, Yuh-Chen, et al.
Publicado: (2016) -
In Patients with Neurogenic Detrusor Overactivity and Hinman’s Syndrome: Would Intravesical Botox Injections Decrease the Incidence of Symptomatic Urinary Tract Infections
por: Banakhar, Mai, et al.
Publicado: (2021) -
AB200. Treatment effect of TURP plus urethral sphincter botox A injection on male neurogenic micturition dysfunction
por: Huang, Xiao, et al.
Publicado: (2016) -
Urinary retention in female OAB after intravesical Botox injection: who is really at risk?
por: Miotla, Pawel, et al.
Publicado: (2016) -
Botulinun A toxin urethral sphincter injection for neurogenic or nonneurogenic voiding dysfunction
por: Kuo, Hann-Chorng
Publicado: (2016)